|
|
||||||||||
|
J Am Coll Cardiol, 2004; 43:386-392, doi:10.1016/j.jacc.2003.09.034 © 2004 by the American College of Cardiology Foundation |



* Cardiology Department, Bichat Hospital, AP-HP, Paris, France
Cardiology Department, Henri Mondor Hospital, Paris, France
Cardiology Department, Tenon Hospital, Paris, France
Cardiac Surgery Department, La Pitié-Sapetrière Hospital, Paris, France
|| Cardiac Surgery Department, Bichat Hospital, Paris, France
Manuscript received April 8, 2003; revised manuscript received July 4, 2003, accepted September 8, 2003.
* Reprint requests and correspondence: Dr. Bernard Iung, Cardiology Department, Bichat Hospital, 46 rue Henri Huchard, 75018 Paris, France.
bernard.iung{at}bch.ap-hop-paris.fr
OBJECTIVES: We sought to evaluate the feasibility and immediate and late results of mitral valve repair (MVRep) for acute and healed endocarditis.
BACKGROUND: Improvements in techniques of MVRep have extended its feasibility in complex lesions, but experience with endocarditis is limited.
METHODS: Among 78 patients operated on for mitral endocarditis between 1990 and 1999, 63 underwent MVRep. The repair was performed for acute endocarditis in 25 patients (40%) at a median of 20 days after the onset of treatment and in 38 patients (60%) for healed endocarditis after a median of 11 months.
RESULTS: Repair of the mitral valve was feasible in 63 patients (81%). This repair involved annuloplasty in 61 patients (97%), valve resection in 49 (78%), shortening or transposition of chordae in 29 (46%), suture of perforation in 18 (29%), a pericardial patch in 12 (19%), and a partial mitral homograft in 7 (11%). Associated procedures were aortic valve replacement in 11 patients, bypass grafting in 3, and tricuspid repair in 2. Early complications were two deaths (3.2%), one re-operation for severe mitral regurgitation and one re-operation for subsequent aortic endocarditis. The seven-year rate of event-free survival was 78 ± 6% in the global series. Multivariate predictors of event-free survival were hypertension (p < 0.006) and intervention for acute endocarditis (p < 0.026). Five-year survival rates were 96 ± 4% after MVRep for acute endocarditis and 91 ± 5% for healed endocarditis.
CONCLUSIONS: Mitral valve repair is frequently feasible and gives good results in patients with infective endocarditis. Patients operated on for acute endocarditis experience more events during follow-up than those operated on after healed endocarditis but have excellent late survival.
| ||||||||||||||
This article has been cited by other articles:
![]() |
M. A. Smith and D. D. Yuh Bioprosthetic mitral valve implantation for active mitral valve endocarditis in third degree thorax burn. Ann. Thorac. Surg., May 1, 2008; 85(5): 1791 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Acar Early surgery in mitral valve endocarditis: it is sometimes too early Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 947 - 947. [Full Text] [PDF] |
||||
![]() |
L. de Kerchove, J.-L. Vanoverschelde, A. Poncelet, D. Glineur, J. Rubay, F. Zech, P. Noirhomme, and G. El Khoury Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Gammie, S. M. O'Brien, B. P. Griffith, T. B. Ferguson, and E. D. Peterson Influence of Hospital Procedural Volume on Care Process and Mortality for Patients Undergoing Elective Surgery for Mitral Regurgitation Circulation, February 20, 2007; 115(7): 881 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H.H. Feringa, L. J. Shaw, D. Poldermans, S. Hoeks, E. E. van der Wall, R. A.E. Dion, and J. J. Bax Mitral Valve Repair and Replacement in Endocarditis: A Systematic Review of Literature Ann. Thorac. Surg., February 1, 2007; 83(2): 564 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF] |
||||
![]() |
H. H.H. Feringa, J. J. Bax, P. Klein, R. J.M. Klautz, J. Braun, Ernst. E. van der Wall, D. Poldermans, and R. A.E. Dion Outcome after mitral valve repair for acute and healed infective endocarditis Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 367 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
S A Livesey Mitral valve reconstruction in the presence of infection Heart, March 1, 2006; 92(3): 289 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Habib Management of infective endocarditis Heart, January 1, 2006; 92(1): 124 - 130. [Full Text] [PDF] |
||||
![]() |
J. S. Gammie, S. M. O'Brien, B. P. Griffith, and E. D. Peterson Surgical Treatment of Mitral Valve Endocarditis in North America Ann. Thorac. Surg., December 1, 2005; 80(6): 2199 - 2204. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aubert, T. Barreda, C. Acar, P. Leprince, N. Bonnet, R. Ecochard, A. Pavie, and I. Gandjbakhch Mitral valve repair for commissural prolapse: surgical techniques and long term results Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 443 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruttmann, C. Legit, G. Poelzl, S. Mueller, O. Chevtchik, M. Cottogni, H. Ulmer, O. Pachinger, G. Laufer, and L. C. Mueller Mitral valve repair provides improved outcome over replacement in active infective endocarditis J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Nadji, J P Remadi, F Coviaux, A Ali Mirode, A Brahim, M Enriquez-Sarano, and C Tribouilloy Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens Heart, July 1, 2005; 91(7): 932 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zegdi, M. Debieche, C. Latremouille, D. Lebied, C. Chardigny, J.-M. Grinda, S. Chauvaud, A. Deloche, A. Carpentier, and J.-N. Fabiani Long-Term Results of Mitral Valve Repair in Active Endocarditis Circulation, May 17, 2005; 111(19): 2532 - 2536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The year in valvular heart disease J. Am. Coll. Cardiol., January 4, 2005; 45(1): 111 - 122. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |